Interactive Transcript
0:00
Radiology pathology.
0:01
Correlation is an important part of doing breast procedures,
0:06
and this should be performed
0:08
by the radiologist who did the procedure.
0:11
The diagnosis must make sense in terms
0:14
of the imaging appearance.
0:16
If the results are discordant, meaning they don't make sense
0:19
with the imaging appearance, we may need to repeat a biopsy,
0:23
maybe use a different modality for guidance
0:25
or potentially excise that part of the breast.
0:30
If there are any questions, reach out to your pathologist.
0:33
Um, go over what the diagnosis is.
0:36
Do they think a radial scar in a biopsy for calcifications
0:40
is related or is it incidental?
0:42
There are lots of incidental findings
0:43
that don't necessarily need to be addressed
0:47
if the biopsy was for calcifications.
0:50
It's important to note whether
0:52
or not calcifications were in the specimen radiograph
0:56
for evaluation of concordance.
0:59
There are some times where we target calcifications
1:02
and we may take a second sample after retargeting,
1:05
but we still don't get the calcifications.
1:08
It's hard to say a benign pathology result is concordant.
1:13
If you haven't gotten the calcifications.
1:16
On the flip side, if you haven't gotten the calcifications,
1:20
but your diagnosis is cancer, then
1:24
you don't need to repeat the biopsy.
1:26
There are cases of Noncalcified DCIS.
1:30
We know that the extent of disease is larger than the
1:33
mammographic uh, representation.
1:35
So in a positive case, um, it may be acceptable not
1:39
to have seen the calcifications in the specimen radiograph.
1:43
The pathologist should comment on the presence
1:46
or absence of calcifications if calcification was
1:50
the target of the biopsy.
1:53
If the specimen contains, uh, both benign
1:56
and malignant processes, I want the pathologist
1:59
to tell me which process is associated
2:02
with the target calcifications.
2:05
For example, if the specimen has both fibrocystic change
2:11
and DCIS
2:13
and the biopsy was rec calcifications,
2:16
if the calcifications are associated
2:19
with the fibrocystic change,
2:21
even if there are residual calcifications,
2:24
they may not all need to be excised, um,
2:26
because that's a benign process for
2:31
noncalcified targets.
2:33
Um, your pretest probability of cancer
2:36
is really important
2:38
because we don't have the specimen radiograph
2:43
to establish satisfactory sampling.
2:46
The clip location on the post biopsy mammogram, uh,
2:51
will help you determine whether
2:52
or not you biopsy the right, uh, location in the breast.
2:57
And for these,
2:59
Uh, targets, I find that
3:01
tomosynthesis on the post biopsy imaging can be very helpful
3:06
for evaluating the presence
3:08
or absence of really a minute residual lesion
3:12
or calcifications.
3:13
In these patients with noncalcified targets,
3:17
a post biopsy hematoma may obscure your underlying target.
3:22
And so if the diagnosis is, uh, benign breast tissue
3:26
and you targeted a mass, it may be useful
3:29
to have the patient come back in a couple of weeks
3:32
to make sure the clip is in the right location
3:35
after the post biopsy changes resolve
3:39
and some, uh, findings,
3:41
even if the pathology is discordant,
3:44
may still require excision.
3:47
For example, a large area
3:48
of architectural distortion if radial scar is found on the
3:52
pathology, if it's a large area,
3:55
they still may need excision.
3:57
So post biopsy mammogram is important to show whether
4:00
or not the clip is in the right spot.